Answers are grounded in this paper and cite their sources.
Narrative review reveals the need for higher-quality non-invasive staging tools in chronic liver disease, highlighting limitations before replacing repeated liver biopsy.
There is an increasing desire for non‐invasive tests to assess both the stage of liver fibrosis and the rate of progression of fibrogenic chronic liver diseases and so reduce the need for repeated liver biopsies. However, higher quality non‐invasive diagnostic procedures are still needed
No takes yet. Share an insight, caveat, or question.
Massimo Pinzani (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: